TR201722910A2 - Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari - Google Patents

Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari Download PDF

Info

Publication number
TR201722910A2
TR201722910A2 TR2017/22910A TR201722910A TR201722910A2 TR 201722910 A2 TR201722910 A2 TR 201722910A2 TR 2017/22910 A TR2017/22910 A TR 2017/22910A TR 201722910 A TR201722910 A TR 201722910A TR 201722910 A2 TR201722910 A2 TR 201722910A2
Authority
TR
Turkey
Prior art keywords
distributable
deferasirox
water containing
tablet formulations
containing deferasirox
Prior art date
Application number
TR2017/22910A
Other languages
English (en)
Inventor
Türkyilmaz Ali̇
Yildirim Edi̇z
Muratoğlu Yeşi̇m
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/22910A priority Critical patent/TR201722910A2/tr
Priority to PCT/TR2018/050931 priority patent/WO2019151967A2/en
Priority to EP18899014.7A priority patent/EP3731812A2/en
Publication of TR201722910A2 publication Critical patent/TR201722910A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, deferasiroks veya deferasiroksun farmasötik olarak kabul edilebilir bir tuzunu içeren formülasyonlar ile ilgilidir. Daha özel olarak mevcut buluş, deferasiroksun suda dağılabilen tablet formülasyonları ile ilgilidir.
TR2017/22910A 2017-12-29 2017-12-29 Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari TR201722910A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/22910A TR201722910A2 (tr) 2017-12-29 2017-12-29 Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari
PCT/TR2018/050931 WO2019151967A2 (en) 2017-12-29 2018-12-28 Water-dispersible tablet formulations comprising deferasirox
EP18899014.7A EP3731812A2 (en) 2017-12-29 2018-12-28 Water-dispersible tablet formulations comprising deferasirox

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/22910A TR201722910A2 (tr) 2017-12-29 2017-12-29 Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari

Publications (1)

Publication Number Publication Date
TR201722910A2 true TR201722910A2 (tr) 2019-07-22

Family

ID=67180857

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/22910A TR201722910A2 (tr) 2017-12-29 2017-12-29 Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari

Country Status (3)

Country Link
EP (1) EP3731812A2 (tr)
TR (1) TR201722910A2 (tr)
WO (1) WO2019151967A2 (tr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129541A (en) 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound
GB0408078D0 (en) 2004-04-08 2004-05-12 Novartis Ag Organic compounds
CN101291655A (zh) 2005-10-19 2008-10-22 诺瓦提斯公司 包含地拉罗司(deferasirox)的分散片
US20090142395A1 (en) * 2007-11-19 2009-06-04 Uri Zadok Deferasirox pharmaceutical compositions
TR201103691A2 (tr) 2011-04-15 2011-08-22 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Deferasiroks dağılabilir tablet formülasyonu.
CZ2012743A3 (cs) * 2012-10-31 2014-05-07 Zentiva, K.S. Dispergovatelné tablety obsahující deferasirox
PL2946771T3 (pl) * 2014-05-20 2019-10-31 Sanovel Ilac Sanayi Ve Ticaret As Preparat w postaci dyspergowalnej w wodzie tabletki zawierający deferazyroks
WO2016167729A1 (en) * 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
WO2018208242A1 (en) * 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability

Also Published As

Publication number Publication date
WO2019151967A3 (en) 2019-10-17
EP3731812A2 (en) 2020-11-04
WO2019151967A2 (en) 2019-08-08

Similar Documents

Publication Publication Date Title
MX2017007629A (es) Compuestos inhibidores de bcl-xl que tienen una baja permeabilidad en las celulas y conjugados de anticuerpo-farmaco que los incluyen.
MA43187B1 (fr) Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
MX2017016619A (es) Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos.
PH12016501252A1 (en) Novel tetrahydropyridopyrimidine compound or salt thereof
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
PH12017500120A1 (en) Methods of improving myocardial performance in fontan patients using udenafil compositions
TWD180369S (zh) 無儲水桶式逆滲透淨水器
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
TR201901516T4 (tr) Nöroprotektif ajanlar ve bunların kullanımları.
MX2018005358A (es) Comprimido de dosis alta que contiene mesalazina optimizado.
EA201692569A1 (ru) Полимиксины с низкой степенью замещения и композиции, их содержащие
MX2020002793A (es) Composiciones de microesferas de gas encapsulado en lipidos y metodos relacionados.
TR201909052T4 (tr) Deferasiroks içeren suda dağılabilen tablet formülasyonu.
TR201722910A2 (tr) Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari
PH12016502592A1 (en) 3'-substituted-abscisic acid derivatives
EA201691422A1 (ru) Перорально распадающиеся таблетированные составы мемантина
EA201791596A1 (ru) Пиразоловые соединения
TR201721065A2 (tr) Deksmedetomi̇di̇n i̇çeren li̇yofi̇li̇ze farmasöti̇k formülasyonlar
TR201819312A2 (tr) Fesoterodi̇ni̇n çi̇ft katmanli tablet formülasyonu
鹿晗 Reloaded I
Wei A Study of English Nominalization from A Grammatical Metonymy Perspective
郑林茂 Do We Need to Protect Our Dialects?
EA201991993A1 (ru) Применение фенилкреатина в качестве ноотропного агента